Novel Insights into Actions of Bisphosphonates on Bone: Differences in Interactions with Hydroxyapatite

Nancollas, G.H., Tang, R., Phipps, R.J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R.G.G. +1 more·2006·Bone
DOI 10.1016/j.bone.2005.05.003

Cited by (865)

Items 601–700 of 865

  1. Acute Management of Hypercalcemia
    Salvatore Minisola, Elisabetta Romagnoli, Vincenzo Carnevale, Alfredo Scillitani · 2014 · Elsevier eBooks
  2. The impact of persistence with bisphosphonates on health resource utilization and fracture risk in the UK : a study of patient records from the UK C linical P ractice R esearch D atalink
    Samara Ferguson, Maurille Feudjo Tepie, Andrew Taylor, Andrew Roddam, Cathy W. Critchlow, Mazhar Iqbal, Leslie Spangler, Jonathan Bayly · 2015 · Journal of Evaluation in Clinical Practice
  3. Synthesis of an analogue of the bisphosphonate drug Ibandronate for targeted drug-delivery therapeutic strategies
    Nicolas Camper, Christopher J. Scott, Marie E. Migaud · 2010 · New Journal of Chemistry
  4. Drug Insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men
    Sue A. Brown, Theresa A. Guise · 2007 · Nature Clinical Practice Urology
  5. Tracking calcification in tissue-engineered bone using synchrotron micro-FTIR and SEM
    Anthony J. Deegan, Gianfelice Cinque, Katia Wehbe, Sandeep Konduru, Ying Yang · 2014 · Analytical and Bioanalytical Chemistry
  6. Fourier Transform Infrared Imaging as a Tool to Chemically and Spatially Characterize Matrix-Mineral Deposition in Osteoblasts
    Meghan E. Faillace, Roger J. Phipps, Lisa M. Miller · 2012 · Calcified Tissue International
  7. Osteoporosis management: translating research into optimal fracture protection II
    Andrea J. Singer, Steven Boonen · 2008 · Current Medical Research and Opinion
  8. A mechanistic study of the interaction of water-soluble borate glass with apatite-bound heterocyclic nitrogen-containing bisphosphonates
    Chandrani Pramanik, Parveen Sood, Li‐na Niu, He Yuan, Sushanta Ghoshal, Walter E. Henderson, Yaodong Liu, Seung Soon Jang, Satish Kumar, David Henry Pashley et al. · 2015 · Acta Biomaterialia
  9. On the surface properties of biodegrading magnesium and its alloys: a survey and discussion
    J L Wang, Nicholas Travis Kirkland, Xiaobo Chen, Jessica Anne Lyndon, N. Birbilis · 2015 · Surface Topography Metrology and Properties
  10. Effects of Alendronate on Bone Remodeling Around Osseointegrated Implants in Rats
    Kyung Chul Oh, Woojin Hwang, Young‐Bum Park, Jae Hoon Lee, Hong‐Seok Moon, Jee‐Hwan Kim · 2016 · Implant Dentistry
  11. Evaluation of the interaction between hydroxyapatite and bisphosphonate by nonlinear capillary electrochromatography
    Deying Kong, Zilin Chen · 2017 · Journal of Separation Science
  12. A new fluorescently labeled bisphosphonate for theranostics in tumor bone metastasis
    Ya‐Xi Ye, Jing Zhi Guan, Xinyue Chen, Yawen Yu, Zhu-Min Xu, Shang-Ming-Zhu Zeng, Zhong‐Chang Wang, Bao‐Zhong Wang, Qingcai Jiao, Hai‐Liang Zhu · 2021 · Talanta
  13. Italian guidelines for the diagnosis and treatment of Paget’s disease of bone
    S. Adámi, P. Bartolazzi, Maria Luisa Brandi, Alberto Falchetti, Paolo Filipponi, Stefano Gonnelli, G. Bianchi, Giancarlo Isaia, Rannuccio Nuti · 2011 · Reumatismo
  14. Treatment of Medication-Related Osteonecrosis of the Jaw Without and With the Use of Advanced Platelet-Rich Fibrin: A Retrospective Clinical Study
    Paulina Adamska, Marcin Stasiak, Natalia Kobusińska, Michał Bartmański, Adam Zedler, Michał Studniarek · 2025 · Journal of Functional Biomaterials
  15. Targeting bone in cancer therapy: Advances and challenges of bisphosphonate-based drug delivery systems
    Fariba Ganji, Mohammadmahdi Eshaghi, Hossein Shaki, Lobat Tayebi · 2025 · ADMET & DMPK
  16. Aminobisphosphonates: Reconsideration 25 years after their approval for the treatment of osteoporosis
    J. González Macías, José Manuel Olmos · 2022 · Medicina Clínica (English Edition)
  17. Scaffolds as Carriers of Drugs and Biological Molecules for Bone-Tissue Bioengineering
    И. А. Хлусов, Ekaterina D. Porokhova, Комарова Екатерина Геннадьевна, Ekaterina A. Kazantseva, Yu. P. Sharkeev, Kristina Alekseevna Yurova, Larisa Sergeevna Litvinova · 2022 · Cell and Tissue Biology
  18. Establishment of bone-targeted nano-platform and the study of its combination with 2-deoxy-d-glucose enhanced photodynamic therapy to inhibit bone metastasis
    Wanzhen Li, Yongqi Yang, Jun Wang, Ting Ge, Shuixia Wan, Lin Gui, Yugui Tao, Ping Song, Liangjun Yang, Fei Ge et al. · 2023 · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials
  19. 3D-printed biomaterial-based scaffolds loaded with zoledronic acid functionalised ceramic microparticles for sustained release
    Aikaterini Dedeloudi, Laura Martinez‐Marcos, Thomas Quinten, Sune Klint Andersen, Dimitrios A. Lamprou · 2025 · International Journal of Pharmaceutics
  20. Synthesis and in vivo anti- or pro-inflammatory activity of new bisphosphonates and vinylphosphonates
    Oscar Abelardo Ramírez‐Marroquín, María Adelina Jiménez-Arellanes, Abimelek Cortes Pacheco, Oscar René Zambrano-Vásquez, Adolfo López-Torres · 2019 · Monatshefte für Chemie - Chemical Monthly
  21. The extract of Trachelospermum jasminoides (Lindl.) Lem. vines inhibits osteoclast differentiation through the NF-κB, MAPK and AKT signaling pathways
    Tao Jiang, Wei Yan, Bo Kong, Changgui Wu, Kai Yang, Tianqi Wang, Xueming Yan, Lei Guo, Ping Huang, Min Jiang et al. · 2020 · Biomedicine & Pharmacotherapy
  22. Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells
    Salah Ahmed Sheweita, Rania G. Ammar, Sally A. Sabra, Ahmed Sultan · 2020 · Journal of Taibah University Medical Sciences
  23. Biomimetic adhesion motifs based on RAFT polymers with phosphonate groups
    Patrick Steinbauer, Andreas Rohatschek, Orestis G. Andriotis, Nikolaos Bouropoulos, Robert Liska, Philipp J. Thurner, Stefan Baudis · 2020 · European Polymer Journal
  24. Oral Surgery Procedures in a Patient with Hajdu-Cheney Syndrome Treated with Denosumab—A Rare Case Report
    Magdalena Kaczoruk-Wieremczuk, Paulina Adamska, Łukasz Jan Adamski, Piotr Wychowański, Barbara Alicja Jereczek‐Fossa, Anna Starzyńska · 2021 · International Journal of Environmental Research and Public Health
  25. Non-Invasive Physical Plasma Treatment after Tooth Extraction in a Patient on Antiresorptive Medication Promotes Tissue Regeneration
    Benedikt Eggers, Matthias Bernhard Stope, Alexander Mustea, Marjan Nokhbehsaim, Nils Heim, Franz‐Josef Kramer · 2022 · Applied Sciences
  26. Antiosteoporotic Nanohydroxyapatite Zoledronate Scaffold Seeded with Bone Marrow Mesenchymal Stromal Cells for Bone Regeneration: A 3D In Vitro Model
    Matilde Tschon, Elisa Boanini, Maria Sartori, Francesca Salamanna, Silvia Panzavolta, Adriana Bigi, Milena Fini · 2022 · International Journal of Molecular Sciences
  27. Structural insights into the binding of zoledronic acid with RANKL via computational simulations
    Ruijie Wang, Wenjie Zhang, Hailong Ma, Duohong Zou, Zhiyuan Zhang, Shaoyi Wang · 2022 · Frontiers in Molecular Biosciences
  28. Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
    Ege Can Şerefoğlu · 2010 · Therapeutics and Clinical Risk Management
  29. Synthesis, Solution, and Structural Characterization of Tetrahydrofuranyl‐2,2‐Bisphosphonic Acid Disodium Salt
    Elena Maltezou, Marios Stylianou, Sudeshna Roy, Chryssoula Drouza, Anastasios D. Keramidas · 2010 · Bioinorganic Chemistry and Applications
  30. Experimental and in silico investigations of organic phosphates and phosphonates sorption on polymer-ceramic monolithic materials and hydroxyapatite
    Monika Zielińska, Joanna Zembrzuska, Rafał Tomczak, Jakub Mikołajczyk, Danuta Rusińska‐Roszak, Adam Voelkel, Tomasz Buchwald, Josef Jampílek, Miloš Lukáč, Ferdinand Devı́nsky · 2016 · European Journal of Pharmaceutical Sciences
  31. Radiolabeling of zoledronic acid with 188Re as a new palliative agent radiotracer in treatment of bone tumors
    Mostafa Erfani, Mina Tabatabaei, Alireza Doroudi, Mohammad Shafiei · 2018 · Journal of Radioanalytical and Nuclear Chemistry
  32. Self-assembled monolayer of mica coating using organobisphosphonic acid
    Guanghui Li, Zheng Shuilin, Bai Chunhua, Xingdong Li, Cheng Changmei · 2018 · Applied Surface Science
  33. Feedback-Controlled Release of Alendronate from Composite Microparticles
    Sofia S. H. Matrali, Anita K. Ghag · 2020 · Journal of Functional Biomaterials
  34. Bisphosphonates
    Dima L. Diab, Nelson B. Watts, Paul D. Miller · 2013 · Elsevier eBooks
  35. Osteonecrosis of Maxilla Secondary to Bisphosphonate Therapy: A Case Report
    Trupti Kolur, Sanjiv Nair, Balasubramanya Kumar · 2011 · Journal of Maxillofacial and Oral Surgery
  36. Ibandronate affects bone growth and mineralization in rats with normal and reduced renal function
    Dagmar‐Christiane Fischer, Claudia Jensen, Anja Rahn, Birgit Salewski, Günther Kundt, Geert J. S. Behets, Patrick C. D’Haese, Dieter Haffner · 2010 · Pediatric Nephrology
  37. Combined Use of Ibandronate and Eldecalcitol in Postmenopausal Japanese Women with Osteoporosis
    Junichi Takada, Hiroshi Wada, Kousuke Iba, Kouichi Sasaki, Takayuki Dohke, Kumiko Kanaya, Takashi Yoshizaki, Toshihiko Yamashita · 2016 · Journal of orthopaedic surgery
  38. Comparison of the efficacy between once-monthly oral ibandronate and risedronate among Korean women with osteoporosis: a nationwide population-based study
    Dong Ryul Lee, Jungun Lee · 2018 · Osteoporosis International
  39. Simple and effective synthesis of functionalized (hydroxymethylene)bis(phosphonic) acids
    Anastasia M. Zhirkova, Kirill Vladimirovich Zaitsev, Andrey A. Prishchenko, Mikhail V. Vasiliev, Marina V. Kotova, Karina A. Uschakova, Laura A. Martirosyan, Irina Vasil'yevna Perminova · 2024 · Mendeleev Communications
  40. The effect of bisphosphonate acidity on the activity of a thymidylyltransferase
    Stephen A. Beaton, Patricia Jiang, Jonathan C. Melong, Matthew W. Loranger, Samy Mohamady, Thomas Veinot, David L. Jakeman · 2013 · Organic & Biomolecular Chemistry
  41. Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
    Mikio Kamimura, Yukio Nakamura, Shota Ikegami, Masatoshi Komatsu, Shigeharu Uchiyama, Hiroyuki Kato · 2016 · Osteoporosis and Sarcopenia
  42. A clinician's guide to the management of geriatric musculoskeletal disease: Part 1 - Osteoporosis
    Jack Feehan, Nicholas Tripodi, Michael Fleischmann, Jesse Zanker, Gustavo Duque · 2021 · International journal of osteopathic medicine
  43. BIFUNCTIONAL BISPHOSPHONATES FOR DELIVERING BIOMOLECULES TO BONE
    Jivan N. Yewle · 2012 · UKnowledge (University of Kentucky)
  44. The performance of a scaffold bioglass–chitosan in the treatment of bone defect
    Salha Boulila, Hassane Oudadesse, Rim Kallel, Ferdaws Ghrab, Bertrand Lefeuvre, Tahia Sellami Boudawara, Abdelfattah Elfeki, Hafed Elfeki · 2018 · Polymer Bulletin
  45. Matrix-Bound Zolzoledronate Enhances the Biofilm Colonization of Hydroxyapatite: Effects on Osteonecrosis
    Ranya Elsayed, Ahmed El‐Awady, Christopher W. Cutler, Zoya Kurago, Mahmoud Elashiry, Christina Sun, Ryan F. Bloomquist, Mohamed M. Meghil, Mohammed E. Elsalanty · 2021 · Antibiotics
  46. Nano silver particles catalyzed synthesis, molecular docking and bioactivity of α-thiazolyl aminomethylene bisphosphonates
    Sreelakshmi Poola, Mohan Gundluru, Maheshwara Reddy Nadiveedhi, Madhu Sudhana Saddala, Prasada Rao P. T. S. R. K., C. Suresh Reddy · 2019 · Phosphorus, sulfur, and silicon and the related elements
  47. Zoledronic acid for treatment of Paget's disease of bone
    Jean‐Pierre Devogelaer, Daniel Henri Manicourt · 2007 · Expert Opinion on Pharmacotherapy
  48. Bisphosphonate Therapy for Secondary Osteoporosis: Adult Perspective
    Ian R. Reid · 2011 · Hormone Research in Paediatrics
  49. Surgical trauma and low-dose methylprednisolone modulate the severity of the acute-phase response induced by zoledronic acid infusion
    Jian Chen, Lipeng Yu, Lixin Chen, Xuan Wu, Pengyu Tang, Jian Yin, Tao Jiang, Guoyong Yin, Jin Fan · 2017 · Experimental and Therapeutic Medicine
  50. Effect of Pre- and Post-Surgery Treatment with Risedronate on Trabecular Bone Loss in Ovariectomized Rats
    Jun Iwamoto, Tsuyoshi Takeda, Yoshihiro Satō, Chwan‐Li Shen, James K. Yeh · 2006 · EXPERIMENTAL ANIMALS · Retracted
  51. All Bisphosphonates Are (or May Not Be) the Same: Potential Reasons for Clinical Differences
    Paul D. Miller · 2010 · Journal of Women s Health
  52. Can clodronate be effective in the treatment of disabling hydroxyapatite crystal-deposition disease? A report of two cases
    Gianantonio Saviola, Lul Abdì-Alì, Paola Baiardi, Maurizio Benucci · 2010 · Rheumatology International
  53. Unwrapping microcomputed tomographic images for measuring cortical osteolytic lesions in the 5T2 murine model of myeloma treated by bisphosphonate
    Mambaye N’Diaye, Hélène Libouban, Eric Aguado, Béatrice Bouvard, Maurice Audran, Daniel Chappard · 2014 · Micron
  54. Emerging Issues With Bisphosphonates
    Ian R. Reid · 2006 · Rheumatic Disease Clinics of North America
  55. ATF4, DLX3, FRA1, MSX2, C/EBP-ζ, and C/EBP-α Shape the Molecular Basis of Therapeutic Effects of Zoledronic Acid in Bone Disorders
    Faroogh Marofi, Jalal Choupani, Saeed Solali, Ghasem Vahedi, Ali Hassanzadeh, Tohid Gharibi, Majid Farshdousti Hagh · 2020 · Anti-Cancer Agents in Medicinal Chemistry
  56. Role of G protein-associated membrane receptors in the pathogenesis of osteoporosis
    Alisa P. Domnina, Olga A. Krasnova, Karina A. Kulakova, Julia V. Sopova, Vitaliy V. Karelkin, O. M. Lesnyak, Irina E. Neganova · 2022 · Translational Medicine
  57. Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins
    Stephanie Seneff, Nancy L. Swanson, Gerald Koenig, Chen Li · 2016 · Disease Markers
  58. Clinical and translational pharmacology of bisphosphonates
    Serge Cremers, Matthew T. Drake, Frank H. Ebetino, Michael J. Rogers, John Paul Bilezikian, R.G.G. Russell · 2019 · Elsevier eBooks
  59. Are All Bisphosphonates the Same? Potential Reasons for Clinical Differences: A Perspective
    James A. Simon · 2010 · Journal of Women s Health
  60. Ibandronate: A Review in Japanese Patients with Osteoporosis
    Gillian M. Keating · 2016 · Drugs & Aging
  61. Treatment of Paget’s Disease of Bone
    Ian R. Reid · 2016 · Elsevier eBooks
  62. Osteonecrosis of the Jaw and Atypical Femoral Fractures
    Elizabeth J. Shane, Sundeep Khosla, David Burr · 2013 · Elsevier eBooks
  63. Anticancer activity of novel surface functionalized metal doped hydroxyapatite
    Pradhan Saheli, Shouvik Mitra, Arunava Goswami · 2020 · Archives of Pharmacy and Pharmaceutical Sciences
  64. Biomimetic Nanostructured Apatitic Matrices for Drug Delivery
    Norberto Roveri, Michele Iafisco · 2012
  65. Phosphate glass fibre reinforced composite for bone repair applications: investigation of interfacial integrity improvements via chemical treatments
    Muhammad Sami Hasan · 2012 · Nottingham ePrints (University of Nottingham)
  66. Bone-targeted and redox-responsive polymeric nanomicelles based on hyaluronic acid
    Mohammad Ali Ghapanvari, Fariba Ganji, Hossein Shaki, Samira Jafarzadeh-Holagh, Ebrahim Vasheghani‐Farahani · 2025 · International Journal of Pharmaceutics
  67. Synthesis of functionalized hydroxymethylene-containing bisorganophosphorus acids
    Yu. N. Bubnov, Andrey A. Prishchenko, Michail V. Livantsov, O. P. Novikova, Ludmila I. Livantsova, S. V. Baranin · 2025 · Russian Chemical Bulletin
  68. Revolutionizing osteoporosis management: the emerging role of immunotherapeutic and next-generation therapies
    Ali Afshari, J. Karami, M. Abbasifard · 2025 · InflammoPharmacology
  69. Bone‐Targeting Selenium‐Doped Carbon Dot‐Based Nanoparticles for Ferroptosis Suppression and Osteogenesis Against Postmenopausal Osteoporosis
    Jingcheng Cao, Qi Dong, Kezheng Du, Mo Zhang, Wei Chen, Zhiyong Hou · 2026 · Advanced Healthcare Materials
  70. Pathogenesis of Medication-Related Osteonecrosis of the Jaw
    Sven Otto, Jose Ignacio Aguirre, Ezher Hamza Dayısoylu, Thomas Ziebart · 2014 · Springer eBooks
  71. Grundlagen des Knochenstoffwechsels und pharmakologische Daten
    Franz Josef Jakob, Dieter Felsenberg · 2013 · Der MKG-Chirurg
  72. Duration of Treatment in Postmenopausal Osteoporosis: How Long to Treat and What are the Consequences of Cessation of Treatment?
    Andrew J. Laster, Simpson Bobo Tanner · 2011 · Rheumatic Disease Clinics of North America
  73. Treat-to-Target in Osteoporosis
    Yasser M El Miedany, Sami M. Bahlas · 2022 · Springer eBooks
  74. Host-guest interaction of anti-carcinogenic drug zoledronic acid with β-cyclodextrin in solid and solution forms
    Gökhan Dıkmen · 2022 · Journal of Molecular Structure
  75. Bisphosphonates on Smooth TiO 2 : Modeling and Characterization
    Leonardo Francisco Gonçalves Dias, João P. C. Rheinheimer, Orisson Ponce Gomes, Paul-Ludwig Michael Noeske, Stephani Stamboroski, Érika Soares Bronze‐Uhle, Maria C. Mainardi, Welchy Leite Cavalcanti, Augusto Batagin‐Neto, Paulo Noronha Lisboa‐Filho · 2022 · ChemistrySelect
  76. Inhibition of osteoclastogenesis after bisphosphonate therapy discontinuation: an in vitro approach
    Vivian Bradaschia-Corrêa, Giovanna Ribeiro-Santos, Lorraine Perciliano de Faria, Paula Rezende Teixeira, Victor Elias Arana-Chavez · 2022 · Journal of Molecular Histology
  77. Bisphosphonates for postmenopausal osteoporosis: a network meta-analysis
    Shu‐Ching Hsieh, Taddele Cherinet Kibret, Jemila S. Hamid, Shannon Kelly, Joan Peterson, Carine Zheng, Peter Tugwell, George A. Wells, Jasvinder A. Singh · 2023 · Cochrane Database of Systematic Reviews
  78. Reducing Fracture Risk in Postmenopausal Osteoporosis: a Review of Effective and Safe Pharmacological Therapy Providing Adherence to Treatment
    Larisa Marchenkova · 2023 · Bulletin of Rehabilitation Medicine
  79. Osteoclasts Link Dysregulated Peripheral Degradation Processes and Accelerated Progression in Alzheimer’s Disease
    Bin Wu, Mulan Chen, Ling Meng, Qiuyun Tian, Zhifang Dong · 2024 · Journal of Alzheimer s Disease
  80. Incidence and clinical course of femoral localized periosteal thickening and atypical femoral fracture over a 10-year period in patients with autoimmune inflammatory rheumatic disease
    Hiroe Sato, Naoki Kondo, Yoichi Kurosawa, Eriko Hasegawa, Ayako Wakamatsu, Yukiko Nozawa, Daisuke Kobayashi, Takeshi Nakatsue, Yoko Wada, Junichiro James Kazama et al. · 2024 · JBMR Plus
  81. Geranylgeranyl diphosphate synthase inhibition impairs osteoclast differentiation, morphology, and resorptive activity
    Molly E. Muehlebach, Staci L. Haney, Yashpal Singh Chhonker, Mamunur Rashid, Daryl J. Murry, Geoffrey A. Talmon, Sarah A. Holstein · 2024 · JBMR Plus
  82. Ultrasound-assisted synthesis of new bisphosphonate–betulin conjugates and preliminary evaluation of their cytotoxic activity
    Dominika Kozicka, Małgorzata Krześniak, Mirosława Grymel, Jakub Adámek, Barbara Łasut-Szyszka, Tomasz Cichoń, Anna Kuźnik · 2025 · RSC Advances
  83. A Facile Crystallization Strategy to Turn Calcium Bisphosphonates into Novel Osteogenesis‐Inducing Biomaterials
    Chen Zhuang, Guanglin Zhu, Yingjun Wang, Lin Wang, Xuetao Shi, Chuanbin Mao · 2023 · Advanced Healthcare Materials
  84. Bisphosphonates for Osteoporosis
    Stuart H. Ralston · 2014 · Springer eBooks
  85. Use of Bisphosphonates in Osteoporosis
    Angelina De Sarro, Letteria Minutoli · 2011 · Springer eBooks
  86. Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?
    MARIUS E. KRAENZLIN, Christian Meier · 2007 · Nature Clinical Practice Endocrinology &#38 Metabolism
  87. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
    Stephen M. Krane · 2006 · Nature Clinical Practice Rheumatology
  88. Implications of the use of bisphosphonates in dental treatment – experience of the service of oral and maxillofacial surgery, Erasto Gaertner Hospital, Curitiba, Brazil
    Regiane Benez Bixofis, Laurindo Moacir Sassi, Cleverson Patussi, William Phillip Pereira da Silva, Roberta Targa Stramandinoli‐Zanicotti, Juliana Lucena Schussel · 2014 · RSBO
  89. MEVALONATE PATHWAY: ROLE OF BISPHOSPHONATES AND STATINS
    Carmelina, Villa Sofia-Cervello · 2011
  90. Bisphosphonates and PTH for Preventing Fractures
    David B. Burr, Matthew R. Allen · 2011 · Studies in mechanobiology, tissue engineering and biomaterials
  91. Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study
    Takaaki Ishida, Shuzo Yoshida, Yuko Kimura, Youhei Fujiki, Takuya Kotani, T Takeuchi, Shigeki Makino, Shigeki Arawaka · 2018 · Lupus
  92. Synthesis andin vivobioactivity of lipophilic alendronate derivatives against osteoporosis
    Tingli Lu, Huijing Hu, Wen Zhao, Tao Chen · 2011 · Drug Development and Industrial Pharmacy
  93. Novel bisphosphonates as inhibitors of isoprenoid biosynthesis
    Brian M. Wasko · 2011
  94. Interventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophy
    Jennifer M Bell, Bronagh Blackwood, Michael David Shields, Janet Watters, Alistair Hamilton, Timothy R. O. Beringer, Mark Elliott, Rosaline C. M. Quinlivan, Sandya Tirupathi · 2014 · Cochrane Database of Systematic Reviews
  95. Osteoblastic cell responses to zoledronate treatment in-vitro: A systematic review
    Maria Florez-Martin, Adriana-Monica Radu, Kaveh Shakib, Gavin Jell · 2026 · Bone
  96. Monthly Risedronate for the Treatment of Postmenopausal Osteoporosis
    Jun Iwamoto · 2014 · Pharmaceutica Analytica Acta
  97. Therapeutic Options in the Prevention and Treatment of Postmenopausal Osteoporosis
    Hosam K. Kamel, Mary Beth O’Connell, Deborah T. Gold · 2006 · Journal of Managed Care Pharmacy
  98. Ostéoradionécrose et ostéonécrose des maxillaires aux bisphosphonates
    Samuel Salino, Anne‐Gaëlle Bodard, Quadiri Timour · 2010
  99. Compressive force strengthened the pro-inflammatory effect of zoledronic acid on il-1ß stimulated human periodontal fibroblasts
    Sarah Grimm, Ambili R. Mundethu, Judit Symmank, Christoph Hennig, Christian Walter, Elisabeth Reichardt, Heiner Wehrbein, Collin Jacobs · 2020 · Clinical Oral Investigations
  100. Ultrasound in Bone Quality Screening: From the Perspective of Osteoporosis
    Sara Rosa de Sousa Andrade, Waldemar Naves do Amaral, Maria Rita de Sousa Silva, Manisha Ashish Rathi, Vinicius de Almeida Lima, Mayara Rios Leite Macedo · 2024 · Medical Journal of Dr D Y Patil Vidyapeeth